Attachment_2_QASP.DOCX
DOCX document 29 KB Posted
- Solicitation number
- W81XWH18R0015
- Issued by
-
Department of the Army Medical Command
About this file
QASP
View the file
Other files
| File | Type | Posted |
|---|---|---|
| A07-18R0015_Amendment_2.docx | DOCX document | |
| A07-18-R-0015_Questions_(Amendment_2).DOCX | DOCX document | |
| 18-R-0015_Questions_(Amendment_1).docx | DOCX document | |
| A07-18R0015_Amendment_1.docx | DOCX document | |
| Attachment_4_OCI.docx | DOCX document | |
| Attachment_3_Non_Disclosure_Statement.docx | DOCX document | |
| Attachment_1_PWS.docx | DOCX document | |
| Attachment_5_Contractor_Cost_Pricing_Sheet.xlsx | XLSX spreadsheet | |
| Attachment_6_Past_Performance_Questionnaire.docx | DOCX document | |
| A07-Solicitation_18R0015_6.6.18.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Quality Assurance Surveillance Plan (QASP) Attachment 2 U.S. Army Center for Environmental Health Research (USACEHR) U.S. Army Medical Research and Materiel Command (USAMRMC)
Global Metabolomics, Lipidomics, and/or Targeted Metabolites of Biospecimens
1. PURPOSE.
This Quality Assurance Surveillance Plan (QASP) provides a systematic method to evaluate contractor performance for the stated contract. This QASP explains the following:
· What will be monitored?
· How monitoring will take place?
· Who will conduct the monitoring?
· How monitoring efforts and results will be documented?
This QASP does not detail how the contractor accomplishes the work. Rather, the QASP is created with the premise that the contractor is responsible for management and quality control actions to meet the terms of the contract. It is the Government’s responsibility to be objective, fair, and consistent in evaluating performance. In addition, the QASP should recognize that unforeseen and uncontrollable situations may occur.
This QASP is a “living document” and the Government may review and revise it on a regular basis. However, the Government shall coordinate changes with the contractor. Updates shall ensure that the QASP remains a valid, useful, and enforceable document. Copies of the original QASP and revisions shall be provided to the contractor and Government officials implementing surveillance activities.
2. GOVERNMENT ROLES AND RESPONSIBILITIES
The following personnel shall oversee and coordinate surveillance activities.
a. Contracting Officer (KO) - The KO shall ensure performance of all necessary actions for effective contracting, ensure compliance with the contract terms, and shall safeguard the interests of the United States in the contractual relationship. The KO shall also assure that the contractor receives impartial, fair, and equitable treatment under this contract. The KO is ultimately responsible for the final determination of the adequacy of the contractor’s performance.
Assigned KO: Laura N. Charles Organization or Agency: US Army Medical Research Acquisition Activity Telephone: Phone: 301-619-8392 Email: laura.n.charles2.civ@mail.mil
b. Contracting Officer’s Representative (COR) – The COR is located at the (Name of Organization and address). The COR will be responsible for technical administration of this contract, and shall assure proper Government surveillance of the contractor’s performance. The COR shall keep a quality assurance file. At the conclusion of the contract or when requested by the KO, the COR shall provide documentation to the KO. A COR is not empowered to make any contractual commitments or to authorize any contractual changes on the Government’s behalf. The contractor shall refer any changes they deem may affect contract price, terms, or conditions to the KO for action.
Primary COR: Valerie T. Divito Telephone: 301-619-7576 Email: valerie.t.divito.civ@mail.mil
Alternate COR: John A. Lewis Telephone: 301-619-7209 Email: john.a.lewis5.civ@mail.mil
CONTRACTOR REPRESENTATIVES:
The following employee of the contractor will serve as the contractor’s Program Manager for this contract.
Program Manager: TBD Title: TBD Telephone: TBD Email: TBD
4. PERFORMANCE STANDARDS.
Performance standards define desired services. The Government performs surveillance to determine if the contractor exceeds, meets or does not meet these standards.
Table 1. Performance Requirement Summary (PRS) Matrix
| Required Task |
| Performance |
Standard
| Method of Surveillance |
| Acceptable Quality Level (AQL) |
| PWS |
| PRS 1. Provide advice on preparing and shipping the biospecimens while preserving the metabolic entities for analysis and evaluate new sample matrices for suitability on metabolomics and lipid platforms used by the Contractor |
| Contractor shall evaluate new sample matrices on analysis instruments to identify optimal sample quantities and extraction conditions for data acceptable data interpretation |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. The COR will review preliminary data to evaluate suitability for additional sample analysis. |
| The conditions and sample quantities recommended by the Contractor will be reviewed, through the use of processed data provided by the contractor for suitability. |
| 3.1.2.1 |
| PRS 2. Perform global metabolomic analysis of biological specimens |
| Contractor shall match control/test groups/ pairs and report relative changes due to exposure and recovery. |
| The COR will correlate report of relative changes to any published results, if any exist. |
| A series of related changes should imply pathway regulation. |
| 3.1.3.1.1 |
| PRS 3. Perform customized sample preparation for global metabolomics. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. |
| The number of metabolites seen shall be greater than 1,000 compounds, with less than 5% process variability (i.e., coefficient of variation) within any sample type. |
| 3.1.3.1.2 |
| PRS 4. Evaluate samples for the presence of metabolites utilizing LC-MS and GC-MS technologies, or another Government-approved technology, for global metabolomics. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. |
| The number of metabolites seen shall be greater than 1,000 compounds, with less than 5% process variability (i.e., coefficient of variation) within any sample type. |
| 3.1.3.1.3 |
| PRS 5. Provide raw and analyzed quantitative data of the relative concentration profile of the small-molecule entities identified in the specimens in a non-proprietary electronic format. |
| Contractor shall provide a quantitative table of all biochemicals, their sub-pathways, and their super-pathways in numerical and heat-map formats. |
| The COR will verify that all metabolic pathways of interest are represented and quantified. |
| Data tables shall contain the numerical value of statistical analyses, including p-values with color coding indicating statistical significance. Median coefficients of variation shall be at or below 5%. |
| 3.1.3.1.4 |
| PRS 6. Deliver a report of the relative concentration profile obtained from small-molecule entities. |
| Contractor shall report if small-molecule entities have been identified in metabolite classes, including, but not limited to, amino acid, cofactor and vitamin, nucleotide, microbiome, carbohydrate, energy, lipid, and novel metabolites. |
| The COR will verify adequate breadth of metabolite coverage. |
| Median coefficients of variation shall be at or below 5%, with at least 1,000 metabolites measured across diverse classes to include, but not limited to, amino acid, cofactor and vitamin, nucleotide, microbiome, carbohydrate, energy, lipid, and novel metabolites. |
| 3.1.3.1.5 |
| PRS 7. Perform Lipidomics analysis. |
| Contractor shall perform both quantitative compositional analysis and deliver complete speciation data. |
| The COR will verify that compositional analysis and speciation data are adequate to evaluate specimen lipid profiles. |
| Absolute quantitation of at least 14 lipid classes shall be attained using a broad library of lipid standards from all identifiable lipid classes. Median coefficient of variation shall not exceed 10% for lipid concentrations. |
| 3.1.3.2.1 |
| PRS 8. Perform customized sample preparation for lipidomics. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample preparation is adequate to identify a broad range of metabolites. |
| Absolute quantitation of at least 14 lipid classes shall be attained with a broad library of lipid standards, allowing identification and quantification of up to 1,100 individual lipid species. |
| 3.1.3.2.2 |
| PRS 9. Evaluate samples for the presence of lipids by utilizing LC-MS and GC-MS technologies, or another Government-approved technology. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. |
| Absolute quantitation of at least 14 lipid classes shall be attained with a broad library of lipid standards, allowing identification and quantification of up to 1,100 individual lipid species. |
| 3.1.3.2.3 |
| PRS 10. Provide absolute quantitation, molecular species concentrations, and complete fatty acid composition of lipid class. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. |
| Absolute quantitation of at least 14 lipid classes shall be attained with a broad library of lipid standards, allowing identification and quantification of up to 1,100 individual lipid species. |
| 3.1.3.2.4 |
| PRS 11. Deliver a report on the fully quantitative profile of lipids, their fatty acid compositions, and abundance of neutral and polar lipid classes. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify metabolic responses. |
| More than 1,100 molecular species, across at least 14 lipid classes, shall be identified and quantified, including principle phospholipid, sphingolipid, and neutral lipid classes. |
| 3.1.3.2.5 |
| PRS 12. Perform targeted metabolite analysis of biological specimens. |
| The Contractor shall supply options for pre-developed assays or initiate the development of a custom assay. |
| The COR will determine whether a pre-developed assay or custom assay will satisfy the Government requirements. |
| More than 250 pre-developed assays shall be made available to the Government to select from, and, where applicable, the Government shall be given the option to develop a custom assay. |
| 3.1.3.3.1 |
| PRS 13. Perform customized sample preparation for targeted metabolomic analysis. |
| Contractor shall report that samples have been run successfully and X numbers of target metabolites were identified. |
| The COR will discuss if sample preparation is adequate to identify the selected target metabolites. |
| The assay shall perform optimally with starting amounts of no more than 100 µL of plasma/serum, 10-50 mg of tissue/fecal material, or 50-100 μL of cell pellet, with median coefficients at or below approximately 10%. |
| 3.1.3.3.2 |
| PRS 14. Evaluate samples for the presence of metabolites by utilizing LC-MS and GC-MS technologies, or another Government-approved technology, for targeted metabolite analysis. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will discuss if sample size is adequate to identify a broad range of metabolites. |
| The assay shall perform optimally with starting amounts of no more than 100 µL of plasma/serum ,10-50 mg of tissue/fecal material, or 50-100 μL of cell pellet, with median coefficients at or below approximately 10%. |
| 3.1.3.3.3 |
| PRS 15. Provide targeted metabolite assays can be used to track biomarkers and improve biological understanding to characterize a particular metabolite. |
| The Contractor shall supply options for predeveloped assays or initiate the development of a custom assay. |
| The COR will determine whether a pre-developed assay or custom assay will satisfy the Government requirements. |
| More than 250 pre-developed assays shall be made available to the Government to select from, and, where applicable, the Government shall be given the option to develop a custom assay. |
| 3.1.3.3.4 |
| PRS 16. Deliver a report of the fully quantitative profile of targeted metabolites. |
| Contractor shall report that samples have been run successfully and X numbers of metabolites were seen. |
| The COR will verify that the targeted metabolites of interest were identified and quantified. |
| The assay shall identify the targeted metabolite(s) of interest with no more than 100 µL of plasma/serum ,10-50 mg of tissue/fecal material, or 50-100 μL of cell pellet, with median coefficients at or below approximately 10% |
| 3.1.3.3.5 |
| PRS 17. Perform statistical and classification analyses of quantitative data. |
| Contractor shall provide information as statistical tables and a final report. |
| The COR will verify appropriateness of statistical tests. |
| Tables, graphs, plots, and charts shall justify statistical significance. |
| 3.1.3.4.1 |
| PRS 18. Ensure that appropriate statistical method is used. |
| Contractor shall provide information as statistical tables and a final report. |
| The COR will evaluate statistical methods for accuracy. |
| Tables, graphs, plots, and charts shall justify statistical significance. |
| 3.1.3.4.2 |
| PRS 19. Deliver a report of the raw data as well as the Statistical and Classification Analysis. |
| Contractor shall provide information as statistical tables and a final report. |
| The COR will evaluate statistical methods for accuracy. |
| Tables, graphs, plots, and charts shall justify statistical significance. |
| 3.1.3.4.3 |
| PRS 20. Provide a biochemical interpretation of selected, statistically significant, named compounds using pathway analysis tools. |
| Contractor shall provide information as a final report. |
| The COR will integrate the reported findings with other pan-omic results for consistency. |
| The significant changes will provide potential biomarkers or druggable targets. |
| 3.1.3.5.1 |
PRS 21. Integrate the biochemical interpretation into a final report deliverable summarizing the statistical and biological conclusions of the study.
| Contractor shall provide information as a final report. |
| The COR will integrate the reported findings with other pan-omic results for consistency. |
| The significant changes will provide potential biomarkers or druggable targets. |
| 3.1.3.6.1.3 |
| PRS 22. Provide access to a Client Portal tool. |
| The Contractor shall provide a remote-access portal that is accessible to Government computers. |
| The COR will access data and perform secondary analyses. |
| The significant changes will provide potential biomarkers or druggable targets. |
| 3.1.3.6.2 |
| PRS 23. Provide access to Web-based tools for intuitive data visualization of lipids. |
| Contractor shall provide a remote-access portal that is accessible to Government computers. |
| The COR will access data and perform secondary analyses. |
| The significant changes will provide potential biomarkers or druggable targets. |
| 3.1.3.6.3 |
| PRS 24. Provide access to Web-based tools for intuitive data visualization of small molecules. |
| Contractor shall provide a remote-access portal that is accessible to Government computers. |
| The COR will access data and perform secondary analyses. |
| The significant changes will provide potential biomarkers or druggable targets. |
| 3.1.3.6.4 |
5. METHODS OF QA SURVEILLANCE.
Various methods exist to monitor performance. The COR shall use the surveillance methods listed below in the administration of this QASP.
· Feedback from Oversight Board
· Feedback from Government Users
· Feedback from Property Book Officers
· Direct Observation
· 100% Inspection
Regardless of the surveillance method, the COR shall always contact the contractor's task manager or on-site representative when a defect is identified and inform the manager of the specifics of the problem. The COR shall be responsible for monitoring the contractor’s performance in meeting a specific performance standard/AQL.
· DIRECT OBSERVATION. (Can be performed periodically or through 100% surveillance.)
· MANAGEMENT INFORMATION SYSTEMS (MIS). (Evaluates outputs through the use of management information reports. Best used for general surveillance and may need to be supplemented by periodic inspections.)
· PERIODIC INSPECTION. Uses a comprehensive evaluation of selected outputs. Inspections may be scheduled as required.
· Analysis of contractor's progress reports. (Evaluate cost, schedule, etc.)
· Performance reporting.
Surveillance results may be used as the basis for actions (to include payment deductions) against the contractor. In such cases, the Inspection of Services clause and the Inspection of Supplies clause in the Contract becomes the basis for the KO’s actions.
6. RATINGS.
Metrics and methods are designed to determine if performance exceeds, meets, or does not meet a given standard and acceptable quality level. A rating scale shall be used to determine a positive, neutral, or negative outcome. The following ratings shall be used:
Example 1:
| EXCEPTIONAL: |
| Performance significantly exceeds contract requirements to the Government’s benefit. |
| SATISFACTORY: |
| Performance meets contractual requirements. |
| UNSATISFACTORY: |
| Performance does not meet contractual requirements. |
7. DOCUMENTING PERFORMANCE.
a. ACCEPTABLE PERFORMANCE.
The Government shall document positive performance. A report template is attached. Any report may become a part of the supporting documentation for fixed fee payments, award fee payments, or other actions.
b. UNACCEPTABLE PERFORMANCE.
When unacceptable performance occurs, the COR shall inform the contractor. This will normally be in writing unless circumstances necessitate verbal communication. In any case the COR shall document the discussion and place it in the COR file.
When the COR determines formal written communication is required, the COR shall prepare a Contract Discrepancy Report (CDR), and present it to the contractor's task manager or on-site representative. A CDR template is attached to this QASP.
The contractor shall acknowledge receipt of the CDR in writing. The CDR will specify if the contractor is required to prepare a corrective action plan to document how the contractor shall correct the unacceptable performance and avoid a recurrence. The CDR will also state how long after receipt the contractor has to present this corrective action plan to the COR. The Government shall review the contractor's corrective action plan to determine acceptability.
Any CDRs may become a part of the supporting documentation for contract payment deductions, fixed fee deductions, award fee nonpayment, or other actions deemed necessary by the KO.
8. FREQUENCY OF MEASUREMENT.
a. Frequency of Measurement.
During contract/order performance, the COR shall take periodic measurements, as specified in the AQL column of the Performance Standards Summary Matrix, and shall analyze whether the negotiated frequency of measurement is appropriate for the work being performed.
b. Frequency of Performance Assessment Meetings.
The COR shall meet with the contractor quarterly to assess performance and shall provide a written assessment.
PERFORMANCE REPORT
1. Contract Number: TBD
2. Prepared by: COR Name Entered At Time of Award
3. Date and time of observation:
4. Observation:
<Examples of items to include in a report are:
- Method of surveillance.
- How frequently you conducted surveillance.
- Surveillance results.
- Number of observations.>
Prepared by: COR
| _______________________________________ | ________________ |
| Signature – Contracting Officer’s Representative | Date |
CONTRACT DISCREPANCY REPORT (CDR)
1. Contract Number: TBD
2. To: (Contractor Task Manager or on-site representative) Philippe Deschamps
3. From: TBD
4. Date and time observed discrepancy:
5. Discrepancy or Problem:
<Describe in detail. Identify any attachments.>
6. Corrective action plan:
A written corrective action plan < is / is not > required.
< If a written corrective action plan is required include the following. > The written Corrective Action Plan will be provided to the undersigned not later than < # days after receipt of this
CDR. >
Prepared by: COR
| ________________________________________________ | ________________ | |
| Signature – Contracting Officer’s Representative | Date |
Received by:
| _________________________________________________ | ________________ |
| Signature - Contractor Task Manager or on-site representative | Date |
The COR may initiate a CDR at any time, including whenever the number of monthly recorded defects for a performance standard exceeds the allowable number of defects; anytime unacceptable performance is determined critical in nature and requires formal corrective action; and whenever an unfavorable trend is detected in contractor performance.
File details come from the government source that posted it.